Changeflow GovPing Healthcare & Life Sciences Metarhizium Pingshaense Fire Ant Control Patent
Routine Notice Added Final

Metarhizium Pingshaense Fire Ant Control Patent

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

A Metarhizium pingshaense strain isolated from wild sources is disclosed as exhibiting high virulence against Solenopsis invicta (red imported fire ants). The strain may be applied directly for ant control or used as a basis for constructing an engineered strain with improved control efficacy. The engineered strain causes infected ant cadavers to volatilize longifolene, an attractant that lures worker ants and disrupts their hygienic behavior, creating a secondary传播 effect. The application was filed on January 17, 2025, and published on April 23, 2026.

“The M. pingshaense strain is a strain isolated from the wild and is highly virulent to the S. invicta.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 268 changes logged to date.

What changed

USPTO published patent application US20260107949A1 covering a naturally isolated Metarhizium pingshaense strain with high virulence toward Solenopsis invicta (red imported fire ant), along with an engineered derivative. The engineered strain is designed to produce longifolene from infected ant cadavers, attracting additional workers and suppressing colony hygiene behavior. CPC classifications span biocontrol compositions (A01N 63/30), insecticides (A01P 7/04), and engineered gene sequences (C12N 9/0008, C12N 15/80).

Entities engaged in biological pesticide research, agricultural biocontrol product development, or commercial fire ant management should review the application's claims for freedom-to-operate implications. The application names five named inventors and covers both the wild-isolated strain and its genetically engineered derivative, making it relevant to parties developing microbial pest control products for turf, agricultural, or structural settings.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

METARHIZIUM PINGSHAENSE STRAIN FOR CONTROLLING SOLENOPSIS INVICTA, AND ENGINEERED STRAIN AND USE THEREOF

Application US20260107949A1 Kind: A1 Apr 23, 2026

Inventors

Weiguo FANG, Meihong NI, Yubo ZHANG, Mingxing JIANG, Xingyuan TANG

Abstract

A Metarhizium pingshaense strain for controlling Solenopsis invicta, and an engineered strain and use thereof are provided, relating to the technical field of controlling Solenopsis invicta. The M. pingshaense strain is a strain isolated from the wild and is highly virulent to the S. invicta. It can be used to control the S. invicta or to construct an engineered strain with improved S. invicta control efficacy. The constructed engineered strain exhibits high virulence to the S. invicta, and enables the ant cadavers infected by the strain to volatilize a large amount of the attractant longifolene of the S. invicta. As a result, the ant cadavers exhibit a luring and killing effect on workers of the S. invicta, significantly limiting the hygienic behavior of the workers.

CPC Classifications

A01N 63/30 A01N 43/54 A01P 7/04 A01P 19/00 C12N 9/0008 C12N 15/80 C12Y 102/01012

Filing Date

2025-01-17

Application No.

19027077

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
January 17th, 2025
Instrument
Notice
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Agricultural firms Manufacturers
Industry sector
1111 Crop Production
Activity scope
Biotech R&D Microbial product development Pest management
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Agriculture Public Health

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!